XT
ETON icon

XTX Topco’s Eton Pharmaceutcials ETON Stock Holding History

XTX Topco’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Sell
5,965
-45,807
-88% -$1.34M ﹤0.01% 3204
2026
Q1 		$1.28M Buy
51,772
+19,245
+59% +$337K 0.02% 1210
2025
Q4 		$550K Buy
32,527
+8,128
+33% +$143K 0.01% 1507
2025
Q3 		$530K Buy
+24,399
New +$405K 0.03% 1033
2025
Q2 		– Sell
-11,797
Closed -$153K – 2581
2025
Q1 		$153K Sell
11,797
-2,858
-20% -$43.2K 0.01% 1761
2024
Q4 		$195K Buy
14,655
+3,351
+30% +$34K 0.02% 1572
2024
Q3 		$67.8K Sell
11,304
-435
-4% -$1.84K ﹤0.01% 1655
2024
Q2 		$38.6K Sell
11,739
-2,364
-17% -$8.27K ﹤0.01% 1537
2024
Q1 		$52.9K Sell
14,103
-8,755
-38% -$38.2K 0.01% 1465
2023
Q4 		$100K Buy
22,858
+10,944
+92% +$43.9K 0.02% 1119
2023
Q3 		$49.7K Buy
+11,914
New +$46K 0.01% 1281
2021
Q4 		– Sell
-14,652
Closed -$74K – 777
2021
Q3 		$74K Sell
14,652
-40
-0.3% -$208 0.02% 583
2021
Q2 		$91K Buy
+14,692
New +$109K 0.03% 670

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

XTX Topco's ETON Position: Q2 2026 in Review

XTX Topco reduced its Eton Pharmaceutcials (ETON) stake by 88% in Q2 2026, selling an estimated $1.34M and leaving 5,965 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

XTX Topco first reported a position in ETON in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.28M in Q1 2026. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • XTX Topco held 5,965 shares of Eton Pharmaceutcials worth $216K as of Q2 2026.
  • XTX Topco sold 45,807 Eton Pharmaceutcials shares in Q2 2026, an estimated $1.34M.
  • Eton Pharmaceutcials made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3204 holding.
  • XTX Topco first reported a position in Eton Pharmaceutcials in Q2 2021 and has held it in 13 quarters since.
  • XTX Topco's Eton Pharmaceutcials position peaked at $1.28M in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.